Busulfan and Visual impairment - a phase IV clinical study of FDA data

Summary:

Visual impairment is reported as a side effect among people who take Busulfan (busulfan), especially for people who are male, 10-19 old, also take Ciclosporin, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Visual impairment when taking Busulfan. It is created by eHealthMe based on reports of 14,527 people who have side effects when taking Busulfan from the FDA, and is updated regularly.

What is Busulfan?

Busulfan has active ingredients of busulfan. eHealthMe is studying from 14,527 Busulfan users. Check the latest studies of Busulfan.

What is Visual impairment?

Visual impairment is found to be associated with 2,249 drugs and 2,336 conditions by eHealthMe. Check the latest studies of Visual impairment.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

14,527 people reported to have side effects when taking Busulfan.
Among them, 21 people (0.14%) have Visual impairment.

Could Busulfan cause Visual impairment?

Among these 21 people:

What is the gender of people who have Visual impairment when taking Busulfan? *

  • female: 27.78 %
  • male: 72.22 %

What is the age of people who have Visual impairment when taking Busulfan? *

  • 0-1: 0.0 %
  • 2-9: 12.5 %
  • 10-19: 50.0 %
  • 20-29: 0.0 %
  • 30-39: 12.5 %
  • 40-49: 6.25 %
  • 50-59: 0.0 %
  • 60+: 18.75 %

What are other drugs people take besides Busulfan? *

  1. Ciclosporin: 9 people, 42.86%
  2. Revlimid: 5 people, 23.81%
  3. Zometa: 3 people, 14.29%
  4. Cytoxan: 3 people, 14.29%
  5. Melphalan: 3 people, 14.29%
  6. Reclast: 3 people, 14.29%
  7. Aredia: 3 people, 14.29%
  8. Pomalidomide: 2 people, 9.52%
  9. Velcade: 2 people, 9.52%
  10. Thalidomide: 2 people, 9.52%

What are other side effects people have besides Visual impairment? *

  1. Headache (pain in head): 12 people, 57.14%
  2. Posterior Reversible Encephalopathy Syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss): 10 people, 47.62%
  3. Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 9 people, 42.86%
  4. High Blood Pressure: 7 people, 33.33%
  5. Nausea And Vomiting: 6 people, 28.57%
  6. Gait Disturbance: 5 people, 23.81%
  7. Fatigue (feeling of tiredness): 5 people, 23.81%
  8. Thrombocytopenia (decrease of platelets in blood): 4 people, 19.05%
  9. Oedema (fluid collection in tissue): 4 people, 19.05%
  10. Pain In Extremity: 4 people, 19.05%

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 8 people, 38.10%
  2. Multiple Myeloma (cancer of the plasma cells): 6 people, 28.57%
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 14.29%
  4. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 9.52%
  5. Age-Related Macular Degeneration: 2 people, 9.52%
  6. Serum Sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum): 1 person, 4.76%
  7. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Busulfan and have Visual impairment?

- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Busulfan:

Visual impairment treatments and more:

How severe was Visual impairment and when was it recovered:

Expand to all the drugs that have ingredients of busulfan:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Busulfan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual impairment:

Browse all the conditions that are associated with Visual impairment:


How the study uses the data?

The study uses data from the FDA. It is based on busulfan (the active ingredients of Busulfan) and Busulfan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: